Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Tag: glucagon


15-LB: Ready-to-Use Glucagon for the Prevention of Exercise-Induced Hypoglycemia during Aerobic Exercise

July 1st 2020

RTUG 150 μg maintained euglycemia during prolonged, continuous, intense aerobic exercise. (Diabetes)

Categories: Medication, News
Tags: glucagon

Categories: Medication
Tags: glucagon

Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)

December 14th 2016

RAMP2 regulates both ligand binding and G protein selectivity of the glucagon receptor (Journal of Biological Chemistry)

Categories: Biochemistry, News
Tags: glucagon

Categories: Biochemistry
Tags: glucagon

Glucagon and heart in type 2 diabetes: new perspectives

August 28th 2016

A possible explanation of the results with the DPPIV inhibitors and empagliflozin might be related to their divergent effect on glucagon levels. Due to unclear effects of glucagon like peptide 1 receptor agonists on glucagon, the possible role of this hormone in the Leader trial remains unclear (Cardiovascular Diabetology)

Categories: Cardiovascular, News
Tags: glucagon, Type 2 Diabetes

Categories: Cardiovascular
Tags: glucagon, Type 2 Diabetes

Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk

April 26th 2016

Glucacon-like peptide-1 receptor agonist and insulin reduced GV, weight, and some cardiometabolic risk markers while maintaining equivalent A1C levels versus BBI and might improve clinical outcomes in a larger trial (Diabetes Care)

Categories: Medication, News
Tags: glucagon, insulin

Categories: Medication
Tags: glucagon, insulin

Glucagon therapeutics, dawn of a new era for diabetes care

January 5th 2016

Although one can never predict that results in animals will be reproduced in humans, the available evidence suggests that type 1 and type 2 diabetic patients may expect far superior control of the metabolic abnormalities without the need for significant monitoring of glucose (Diabetes/Metabolism Research and Reviews)

Categories: News, Treatment
Tags: glucagon

Categories: Treatment
Tags: glucagon

Evidence of Extrapancreatic Glucagon Secretion in Man

December 16th 2015

These findings emphasize the existence of extrapancreatic glucagon (perhaps originating from the gut) in man and suggest that it may play a role in diabetes secondary to total pancreatectomy (Diabetes)

Categories: News, Pathology
Tags: extrapancreatic, glucagon

Categories: Pathology
Tags: extrapancreatic, glucagon

Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System

September 8th 2015

Finding supports the safety of repeated glucagon delivery in the setting of a bihormonal closed-loop system  (Diabetes Care)

Categories: News, Treatment
Tags: glucagon, glycogen, Type 1 Diabetes

Categories: Treatment
Tags: glucagon, glycogen, Type 1 Diabetes

The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes

March 9th 2015

Postprandial glucagon levels were associated with deterioration of glycaemic control and declining beta cell function in the first 5 years after diagnosis of type 1 diabetes (Diabetologia)

Categories: News, Pathology
Tags: beta cell, glucagon

Categories: Pathology
Tags: beta cell, glucagon

Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients

January 6th 2015

Disordered early phase insulin and glucagon secretions but not incretin secretion are involved in hyperglycemia after ingestion of nutrients in T2DM of even a short duration (Journal of Diabetes and Its Complications)

Categories: Biochemistry, Diet, News
Tags: glucagon, hyperglycemia, incretin, insulin, Type 2 Diabetes

Categories: Biochemistry, Diet
Tags: glucagon, hyperglycemia, incretin, insulin, Type 2 Diabetes

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

Napp DiabetesSanofi DiabetesAstraZenecaNovo Nordisk

Silver Sponsors

AmgenWelsh Endocrinology and Diabetes Society (WEDS)About Ascensia Diabetes CareAbbott Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 elderly Empagliflozin exenatide exercise GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis lada liraglutide metformin microvascular mortality NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership